Complaints Outcomes

Search

Search Results

Search Again
Mai , Ha Van Phan (Dec 3, 2018)

Mai, Ha Van Phan (December 3, 2018)

  1. Nature of Action: The Inquiry Committee of the College of Pharmacists of British Columbia (the “College”) conducted an investigation into the practice of Ha Van Phan Mai (the “Registrant”), pursuant to section 33(4) of the Health Professions Act, R.S.B.C. 1996, c. 183.

The Inquiry Committee and the Registrant have agreed to resolve all matters arising from the investigation by way of a Consent Agreement under section 36(1) of the Health Professions Act.

  1. Effective date: December 3, 2018
  1. Name of registrant: Ha Van Phan Mai
  1. Location of Practice: Vancouver, BC
  1. Admissions and Acknowledgements:

Between January 1, 2014 and November 5, 2017, over 15,000 transactions for over-the-counter (“OTC”) and/or vitamin products were processed on a daily or weekly basis on the PharmaNet records of seven individuals. These seven individuals were not prescribed and had not received any of the OTC and/or vitamin products processed on their PharmaNet records, and had not consented to having these transactions on their PharmaNet records.

These transactions all originated from a pharmacy where the Registrant had worked as a full-time pharmacist.

The pharmacy’s manager at the time had directed pharmacy assistants to process these transactions on PharmaNet every Sunday in order to artificially inflate the pharmacy’s prescription count. The pharmacy assistants used the registration numbers of various pharmacist registrants as the dispensing pharmacist and/or prescriber for each transaction, without the consent and knowledge of these pharmacist registrants.

The Registrant has admitted and/or acknowledged the following:

  1. She was aware that the pharmacy’s manager directed the processing of the transactions in order to artificially inflate the pharmacy’s prescription count;
  2. When she had been the pharmacist on duty, she did not directly supervise the activities of the pharmacy assistants that had processed the transactions on Sundays;
  3. She knew, or should have known, that:
    1. The processing of the transactions was an improper use and access of personal information;
    2. There was no patient consent to process the transactions;
    3. Pharmacy assistants are always to be directly supervised; and
    4. Pharmacists must personally review the PharmaNet record for all prescriptions processed;
  4. Even though she knew about these transactions, she did not, at any time, make a report to the College about them.
  1. Disposition:

The Registrant entered into a Consent Agreement with the College’s Inquiry Committee, wherein the Registrant consented to the following terms

  1. To successfully complete and pass an ethics course for healthcare professionals within six months. If she fails to complete this within the specified time period, her registration will be suspended for a period of 30 days;
  2. To successfully pass the College’s Jurisprudence Exam;
  3. To successfully complete and pass the “BC Community Pharmacy Manager Training Program” offered by the British Columbia Pharmacy Association; and
  4. To have a Letter of Reprimand placed permanently on her registration record.
  1. Rationale:

The Inquiry Committee was concerned that the Registrant did not take personal accountability and “turned a blind eye” to the improper practices for which she was aware, enabling the improper practices to continue for over three years. While the Registrant did not stand to gain financially from what occurred, it was her professional responsibility, to the public as well as the profession, to ensure that practice and ethical standards were being met at all times while on duty. As a member of a professional body, registrants are responsible not only for their own actions, but are accountable for others in the workplace when they know, or ought to know, that inappropriate practices were occurring and ongoing. Her actions, or lack thereof, were contraventions of legislation involving protection of personal information and supervision of pharmacy assistants, She also contravened standards of the Code of Ethics involving protecting and promoting the well-being of patients, benefitting society, and committing to personal and professional integrity.

The Inquiry Committee considered the terms of the Consent Agreement necessary to protect the public, as well as send a clear message of deterrence to the profession. Inappropriate access of personal health information, without consent, compromises the public’s trust in the pharmacy profession as a whole. At all times, registrants must uphold legislative requirements and ethical obligations to protect personal health information.

Lu, William Wanyang (Nov 30, 2018)

Lu, William Wanyang (November 30, 2018)

  1. Nature of Action: The Inquiry Committee of the College of Pharmacists of British Columbia (the “College”) conducted an investigation into the practice of William Wanyang Lu (the “Registrant”), pursuant to section 33(4) of the Health Professions Act, R.S.B.C. 1996, c. 183.

The Inquiry Committee and the Registrant have agreed to resolve all matters arising from the investigation by way of a Consent Agreement under section 36(1) of the Health Professions Act.

  1. Effective date: November 30, 2018
  1. Name of registrant: William Wanyang Lu
  1. Location of Practice: Vancouver, BC
  1. Admissions and Acknowledgements:

Between January 1, 2014 and November 5, 2017, over 15,000 transactions for over-the-counter (“OTC”) and/or vitamin products were processed on a daily or weekly basis on the PharmaNet records of seven individuals. These seven individuals were not prescribed and had not received any of the OTC and/or vitamin products processed on their PharmaNet records, and had not consented to having these transactions on their PharmaNet records.

These transactions all originated from a pharmacy where the Registrant had worked as a full-time pharmacist.

The pharmacy’s manager at the time had directed pharmacy assistants to process these transactions on PharmaNet every Sunday in order to artificially inflate the pharmacy’s prescription count. The pharmacy assistants used the registration numbers of various pharmacist registrants as the dispensing pharmacist and/or prescriber for each transaction, without the consent and knowledge of these pharmacist registrants.

The Registrant has admitted and/or acknowledged the following:

  1. He was aware that the pharmacy’s manager directed the processing of the transactions in order to artificially inflate the pharmacy’s prescription count;
  2. When he had been the pharmacist on duty, he did not directly supervise the activities of the pharmacy assistants that had processed the transactions on Sundays;
  3. He knew, or should have known, that:
    1. The processing of the transactions was an improper use and access of personal information;
    2. There was no patient consent to process the transactions;
    3. Pharmacy assistants are always to be directly supervised; and
    4. Pharmacists must personally review the PharmaNet record for all prescriptions processed;
  4. Even though he knew about these transactions, he did not, at any time, make a report to the College about them.
  1. Disposition:

The Registrant entered into a Consent Agreement with the College’s Inquiry Committee, wherein the Registrant consented to the following terms:

  1. To successfully complete and pass an ethics course for healthcare professionals within six months. If he fails to complete this within the specified time period, his registration will be suspended for a period of 30 days;
  2. To successfully pass the College’s Jurisprudence Exam;
  3. To successfully complete and pass the “BC Community Pharmacy Manager Training Program” offered by the British Columbia Pharmacy Association; and
  4. To have a Letter of Reprimand placed permanently on his registration record.
  1. Rationale:

The Inquiry Committee was concerned that the Registrant did not take personal accountability and “turned a blind eye” to the improper practices for which he was aware, enabling the improper practices to continue for over three years. While the Registrant did not stand to gain financially from what occurred, it was his professional responsibility, to the public as well as the profession, to ensure that practice and ethical standards were being met at all times while on duty. As a member of a professional body, registrants are responsible not only for their own actions, but are accountable for others in the workplace when they know, or ought to know, that inappropriate practices were occurring and ongoing. His actions, or lack thereof, were contraventions of legislation involving protection of personal information and supervision of pharmacy assistants, He also contravened standards of the Code of Ethics involving protecting and promoting the well-being of patients, benefitting society, and committing to personal and professional integrity.

The Inquiry Committee considered the terms of the Consent Agreement necessary to protect the public, as well as send a clear message of deterrence to the profession. Inappropriate access of personal health information, without consent, compromises the public’s trust in the pharmacy profession as a whole. At all times, registrants must uphold legislative requirements and ethical obligations to protect personal health information.

Wong, Jason Jonathan (Nov 27, 2018)
  1. Nature of Action: The Inquiry Committee of the College of Pharmacists of British Columbia (the “College”) conducted an investigation into the practice of Jason Jonathan Wong (the “Registrant”), pursuant to section 33(4) of the Health Professions Act, R.S.B.C. 1996, c. 183.

    The Inquiry Committee and the Registrant have agreed to resolve all matters arising from the investigation by way of a Consent Agreement under section 36(1) of the Health Professions Act.

  2. Effective date: November 27, 2018

  3. Name of registrant: Jason Jonathan Wong

  4. Location of Practice: Port Coquitlam, BC

  5. Admissions and Acknowledgements:

    Between January 1, 2014 and November 5, 2017, over 15,000 transactions for over-the-counter (“OTC”) and/or vitamin products were processed on a daily or weekly basis on the PharmaNet records of seven individuals. These seven individuals were not prescribed and had not received any of the OTC and/or vitamin products processed on their PharmaNet records, and had not consented to having these transactions on their PharmaNet records.

    These transactions all originated from a pharmacy where the Registrant had worked as a full-time pharmacist.

    The pharmacy’s manager at the time had directed pharmacy assistants to process these transactions on PharmaNet every Sunday in order to artificially inflate the pharmacy’s prescription count. The pharmacy assistants used the registration numbers of various pharmacist registrants as the dispensing pharmacist and/or prescriber for each transaction, without the consent and knowledge of these pharmacist registrants.

    The Registrant has admitted and/or acknowledged the following:

    1. He was aware that the pharmacy’s manager directed the processing of the transactions in order to artificially inflate the pharmacy’s prescription count;
       
    2. When he had been the pharmacist on duty, he did not directly supervise the activities of the pharmacy assistants that had processed the transactions on Sundays;
       
    3. He knew, or should have known, that:
      1. The processing of the transactions was an improper use and access of personal information;
         
      2. There was no patient consent to process the transactions;
         
      3. Pharmacy assistants are always to be directly supervised; and
         
      4. Pharmacists must personally review the PharmaNet record for all prescriptions processed;
         
    4. Even though he knew about these transactions, he did not, at any time, make a report to the College about them.
       
  6. Disposition:

    The Registrant entered into a Consent Agreement with the College’s Inquiry Committee, wherein the Registrant consented to the following terms:

    1. To suspend his registration as a pharmacist for a total of 60 days, commencing November 27, 2018;
       
    2. To successfully pass the College’s Jurisprudence Exam;
       
    3. To successfully complete and pass an ethics course for healthcare professionals;
       
    4. To successfully complete and pass the “BC Community Pharmacy Manager Training Program” offered by the British Columbia Pharmacy Association;
       
    5. To appear before the Inquiry Committee for a verbal reprimand; and
       
    6. To have a Letter of Reprimand placed permanently on his registration record.

     

  7. Rationale:

    The Inquiry Committee was concerned that the Registrant did not take personal accountability and “turned a blind eye” to the improper practices for which he was aware, enabling the improper practices to continue for over three years. While the Registrant did not stand to gain financially from what occurred, it was his professional responsibility, to the public as well as the profession, to ensure that practice and ethical standards were being met at all times while on duty. As a member of a professional body, registrants are responsible not only for their own actions, but are accountable for others in the workplace when they know, or ought to know, that inappropriate practices were occurring and ongoing. His actions, or lack thereof, were contraventions of legislation involving protection of personal information and supervision of pharmacy assistants, He also contravened standards of the Code of Ethics involving protecting and promoting the well-being of patients, benefitting society, and committing to personal and professional integrity.

    The Inquiry Committee also considered that the Registrant had previously consented to remedial undertakings to fully comply with ethical requirements, and he had breached these undertakings for this current matter. The Inquiry Committee therefore considered the Registrant’s conduct to be serious, and that the Registrant required significant remediation and deterrence in order to come into compliance.

    The Inquiry Committee considered the terms of the Consent Agreement necessary to protect the public, as well as send a clear message of deterrence to the profession. Inappropriate access of personal health information, without consent, compromises the public’s trust in the pharmacy profession as a whole. At all times, registrants must uphold legislative requirements and ethical obligations to protect personal health information.

Pharmacist Registrant 22 (Oct 12, 2018)

The Inquiry Committee has reinstated the pharmacist registrant’s registration which had previously been suspended for an indefinite period on August 13, 2015. Pursuant to Section 36(1) of the Health Professions Act, the Inquiry Committee has reached an Agreement with the pharmacist registrant whereby the pharmacist registrant consented to terms including, but not limited to, the following:

  1. To strictly adhere to his routine medical monitoring program with the institution currently involved in his care and remaining on the monitoring program for a period of at least 3 years;

  2. To comply with any and all recommendations and treatment prescribed or directed by medical professionals involved in his care;

  3. To not work alone in a pharmacy, and to have another pharmacist in good standing supervising him at all times;

  4. To not handle, physically prepare, or dispense prescriptions for opioid medications at any time;

  5. To not have any access whatsoever, on or off duty, to the narcotic safe in any pharmacy;

  6. To not be involved in any way with ordering narcotic medications, except for signing off on the necessary paperwork in the presence of a witnessing pharmacy staff member for the purposes of receiving and stocking such narcotics;

  7. To inform all managers and employers with whom he gains employment of his medical condition and the limits and conditions on his registration pursuant to the Agreement;

  8. To ensure that all managers and employers with whom he gains employment submits a written statement to the College declaring their awareness of his medical condition and the Agreement, and how they will accommodate and supervise him working in the pharmacy;
     
  9. To inform the College in via e-mail of his places of employment as a pharmacist and report any changes to the location of his employment within 48 hours of such change; and

  10. To be restricted from acting in the following roles in his practice:

    1. Be a manager of a pharmacy;
    2. Be an owner (direct or indirect) of a pharmacy; and
    3. Act as a preceptor.

     


August 13, 2015
(October 12, 2018 – Registration Reinstated)

The Inquiry Committee, pursuant to Section 36 of the Health Professions Act, has reached an agreement with the pharmacist registrant to suspend his registration as a pharmacist effective August 13, 2015. The agreement remains in effect until further notice. The Inquiry Committee considers the agreement necessary to protect the public. The pharmacist registrant's name has been withheld pursuant to 39.3(4) of the Health Professions Act.


February 13, 2015
(AUGUST 13, 2015 - Registration Suspended)

The Inquiry Committee has reinstated pharmacist registrant’s registration which had previously been suspended for an indefinite period on August 5, 2014. Pursuant to Section 36 of the Health Professions Act, the Inquiry Committee has reached an Agreement with the pharmacist registrant whereby the Registrant consented to undertakings involving regular monitoring for fitness to practice pharmacy. The undertakings include, but are not limited to:

  1. Routine and random medical monitoring;

  2. Informing all managers and employers with whom Registrant gains employment of Registrant’s medical condition and the limits and conditions on Registrant’s registration pursuant to the agreement;

  3. Ensuring that all managers and employers with whom Registrant gains employment submits a written statement to the College declaring their awareness of Registrant’s medical condition and the agreement, and how they will accommodate and supervise Registrant working in pharmacy;

  4. Registrant will not work alone in a pharmacy setting, meaning that Registrant must never be the sole pharmacist in attendance at any time and that there must be another pharmacist or pharmacy assistant or pharmacy staff working with Registrant at all times;

  5. Registrant will not have access to narcotic-safe or physically process and/or otherwise prepare any prescriptions that require access to the narcotic safe;

  6. Registrant will not be involved in any way with ordering supplies of narcotic medications;

  7. Registrant will not be involved in the dispensing, ordering, contact, destruction, counting or otherwise handling of opiate medications and other medications with abusive potential;

  8. Being restricted from the following roles in Registrant’s practice:

    1. an owner or manager of a pharmacy;
    2. a director of a corporation that owns a pharmacy; and
    3. a preceptor.

     

  9. Notifying the College of:

    1. all changes in his places of employment as a pharmacist
    2. all changes in residential address and phone number; and
    3. all changes in medical provider.

     

The agreement will remain in place for a minimum of three years of continuous pharmacy practice. The name of the Registrant has been withheld in accordance with section 39.3(4)(a) of the Health Professions Act for the purposes of not identifying the personal health information of the Registrant respecting the condition. The Inquiry Committee is satisfied that the undertakings will protect the public. 


August 5, 2014
(February 13, 2015 – Registration reinstated)

The Inquiry Committee, pursuant to Section 36 of the Health Professions Act, has reached an agreement with the pharmacist registrant to suspend his registration as a pharmacist effective August 5, 2014. The agreement remains in effect until further notice. The Inquiry Committee considers the agreement necessary to protect the public. The pharmacist registrant's name has been withheld pursuant to 39.3(4) of the Health Professions Act.

Tahmasebi Boldaji, Ashkan (Oct 10, 2018)

Pursuant to section 36(1) of the Health Professions Act, the Inquiry Committee has reached an Agreement with Ashkan Tahmasebi Boldaji (the “Registrant”) to suspend his registration as a pharmacist for 30 consecutive days commencing December 4, 2018.

While the Registrant was delivering medications to a transitional housing complex the Registrant shoved and pushed a resident of this home out of an elevator resulting in her falling to the ground. The resident appeared to enter the elevator smoking a cigarette and did not put it out when asked by the Registrant. There was no evidence to support a need for self-defence by the Registrant. Additionally, the Registrant’s statements were found to be inconsistent with video evidence.

The Registrant acknowledged that his conduct constituted professional misconduct.

Pursuant to his Agreement, the Registrant also consented to the following:

  • To successfully complete an ethics course for healthcare professionals;
  • To appear before the Inquiry Committee for a verbal reprimand; and
  • To pay a $1000.00 fine.

The Inquiry Committee considers this agreement necessary to protect the public, and to send a clear message to the profession that the College does not tolerate this type of conduct.”

Pharmacy Technician Registrant 4 (Oct 3, 2018)

The Inquiry Committee of the College of Pharmacists of British Columbia (“CPBC”) has reached an agreement with the pharmacy technician registrant to voluntarily suspend her registration as pharmacy technician effective October 3, 2018. The agreement remains in effect until further notice. The Inquiry Committee considers the agreement necessary to protect the public. The pharmacy technician’s name has been withheld pursuant to section 39.3(4)(a) of the Health Professions Act.

Pharmacist Registrant 39 (Sep 24, 2018)

The Inquiry Committee, pursuant to section 32.2(4)(b)(ii) of the Health Professions Act, has reached an agreement with the pharmacist registrant to voluntarily suspend her registration as a pharmacist effective September 24, 2018.  The agreement remains in effect until further notice.  The Inquiry Committee considers the agreement necessary to protect the public.  The pharmacist registrant’s name has been withheld pursuant to section 39.3(4)(a) of the Health Professions Act.

Pharmacist Registrant 38 (Sep 5, 2018)

The Inquiry Committee has reached an agreement with the pharmacist registrant to amend one of the terms in his Agreement of August 2, 2018. While the pharmacist registrant is still limited to working in a pharmacy for no more than four hours a day, he can now work up to eight hours up to two days per week, if necessary to ensure sufficient pharmacist staff levels.


August 2, 2018
(September 5, 2018 - Limits and Conditions Updated)

The Inquiry Committee, pursuant to s. 32.2(4)(b)(i) of the Health Professions Act, has reached an agreement with the pharmacist registrant to place limits and conditions on his pharmacy practice, pending further disposition of the Inquiry Committee. The pharmacist registrant will be limited to working in a pharmacy for no more than four hours a day and must work with another pharmacy staff member at all times. The Inquiry Committee considers this agreement necessary to protect the public. The pharmacist registrant’s name has been withheld pursuant to s. 39.3(4) of the Health Professions Act.

Pharmacist Registrant 26 (Sep 3, 2018)

The Inquiry Committee, pursuant to Section 36(1) of the Health Professions Act, has reached an agreement with the pharmacist registrant to further amend one of the terms in his Agreement of June 4, 2017. The pharmacist registrant can now work in a pharmacy where narcotic/controlled substances and Z-group drugs are counted and reconciled on a monthly basis.


January 17, 2018
(September 3, 2018 - Limits and Conditions Updated)

The Inquiry Committee, pursuant to Section 36(1) of the Health Professions Act, has reached an agreement with the pharmacist registrant to amend one of the terms in his Agreement of June 4, 2017. The pharmacist registrant can now work in a pharmacy where narcotic/controlled substances and Z-group drugs are counted and reconciled on a biweekly basis.


June 4, 2017
(January 17, 2018 - Limits and conditions updated)

The Inquiry Committee, pursuant to Section 36(1) of the Health Professions Act, has reached a new revised Agreement with the pharmacist registrant whereby the registrant consented to undertakings that include, but are not limited to:

  1. Complying with all terms of the registrant’s monitoring program for a minimum of three additional years;

  2. Continuing counselling for one year from the date after he had returned to work;

  3. Informing all managers and employers with whom registrant gains employment of registrant’s medical condition and the limits and conditions on registrant’s registration pursuant to the Agreement;

  4. Ensuring that all managers and employers with whom registrant gains employment submits a written statement to the College declaring their awareness of Registrant’s medical condition and the agreement, and how they will accommodate and supervise registrant working in pharmacy;

  5. Working in a pharmacy where narcotic/controlled substances and Z-group drugs are counted and reconciled on a weekly basis;

  6. Working a maximum number of hours and shifts per week for the first three months after signing the Agreement;

  7. Informing his pharmacy manager of all wastages and breakages of narcotic, controlled, opioid and sedative drugs that he has to dispose of or deal with;

  8. Not conducting drug counts and/or conduct medication reconciliation for any narcotic/controlled substances or Z-group drugs;

  9. The registrant will be restricted from acting in the following roles:

    1. an owner or manager of a pharmacy;
    2. a director of a corporation that owns a pharmacy; and
    3. a preceptor;

     

  10. The registrant will notify the College regarding any of the following changes:

    1. changes in places of employment as a pharmacist;
    2. changes in residential address and phone number; and
    3. changes in medical provider;

     

The Agreement will remain in place for a minimum of four years or until such time as the registrant’s physician states otherwise. The name of the registrant has been withheld in accordance with section 39.3(4)(a) of the Health Professions Act for the purposes of not identifying the personal health information of the registrant. The Inquiry Committee is satisfied that the undertakings will protect the public.


January 3, 2017
(June 4, 2017 – Limits and conditions updated)

The Inquiry Committee has reinstated pharmacist registrant’s registration which had previously been suspended indefinitely on May 16, 2016. Pursuant to Section 36 of the Health Professions Act, the Inquiry Committee has reached an agreement with the pharmacist registrant whereby the registrant consented to undertakings involving regular monitoring for fitness to practice pharmacy. The undertakings include, but are not limited to:

  1. That the registrant will comply with all terms of registrant’s monitoring program with the company currently involved in registrant’s care and remain on this program for a minimum of three (3) years from the day registrant returns to active employment as a pharmacist;

  2. That registrant will continue counselling for one (1) year after registrant returns to work;

  3. That registrant will inform all managers and employers with whom registrant gains employment of registrant’s medical condition and the limits and conditions on registrant’s registration pursuant to this agreement;

  4. That registrant will ensure that all managers and employers with whom registrant gains employment submit a written statement to the College within 48 hours of securing employment, declaring their awareness of registrant’s medical condition and the agreement, how they will accommodate and supervise registrant working in the pharmacy, and that they will submit a weekly narcotic count for a minimum of three (3) months to the College or advise the College if any narcotic count concerns arise;

  5. That after returning to work in a pharmacy setting, registrant will provide work sign-in sheets on a monthly basis;

  6. That registrant will not work alone after returning to work in a pharmacy setting and that there must be overlapping shifts of at least one registrant during registrant’s work shift for a minimum of the first six (6) months that registrant returns to work;

  7. That after returning to work in a pharmacy setting, registrant will not be allowed to dispense narcotics;

  8. That after returning to work in a pharmacy setting, registrant will not handle or physically prepare prescriptions for narcotic, controlled, opioid and sedative drugs, including but not limited to Benzodiazepine, Dextroamphetamine and testosterone products and any Z-Group drugs;

  9. That after returning to work in a pharmacy setting, for the first six (6) months, registrant will not be allowed to dispense Controlled Substances ie. Benzodiazepine, Dextroamphetamine and testosterone products and any Z-Group drugs (which are not considered Controlled Substances);

  10. That after returning to work in a pharmacy setting, registrant will not be allowed to do narcotic or controlled substances or Z-Group drug counts;

  11. That after returning to work in a pharmacy setting, registrant will not dispose or deal with wastage or breakage of or otherwise handle any narcotic, controlled, opioid and sedative drugs, including but not limited to Benzodiazepine, Dextroamphetamine and testosterone products and any Z-Group drugs;

  12. That registrant will not have access to the narcotic-safe or physically process and/or otherwise prepare any prescriptions that require access to the narcotic safe;

  13. That registrant will not be involved in any way with ordering supplies of narcotic medications;

  14. That registrant will be restricted from acting in the following roles in registrant’s practice: 

    1. an owner or manager of a pharmacy;
    2. a director of a corporation that owns a pharmacy; and
    3. a preceptor;

     

  15. That registrant will be restricted from acting in the following roles in registrant’s practice: 

    1. all changes in places of employment as a pharmacist;
    2. all changes in residential address and phone number; and
    3. all changes in medical provider;

The agreement will remain in place for a minimum of five years from the date of execution of the agreement. The registrant will be assessed by the treating physician after six (6) months upon return to active employment to determine whether or not any of the above limits or conditions should be removed. The name of the registrant has been withheld in accordance with section 39.3(4)(a) of the Health Professions Act for the purposes of not identifying the personal health information of the registrant respecting the condition. The Inquiry Committee is satisfied that the undertakings will protect the public.


May 16, 2016
(January 3, 2017 – Registration Reinstated)

The Inquiry Committee, pursuant to section 36 of the Health Professions Act, has reached an agreement with the pharmacist registrant to voluntarily suspend the registration as a pharmacist effective May 16, 2016. The agreement remains in effect until further notice. The Inquiry Committee considers the agreement necessary to protect the public. The pharmacist registrant's name has been withheld pursuant to section 39.3(4) of the Health Professions Act.

Pharmacy Technician Registrant 3 (Sep 1, 2018)

The Inquiry Committee, pursuant to Section 36 of the Health Professions Act, has reached an agreement with pharmacy technician registrant to suspend her registration as a pharmacy technician for an indefinite period pending further decision of the Inquiry Committee. The Inquiry Committee considers the agreement necessary to protect the public. The registered pharmacy technician registrant's name has been withheld pursuant to 39.3(4) of the Health Professions Act.

Pages